ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 12191 recruiting trials
RecruitingNCT06755775 ↗
PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Southeast Asia Dose Optimization of Tafenoquine
👨⚕️ Cindy Chu, MD, PhD, Lao-Oxford-Mahosot Hospital-Wellcome Research Unit📍 5 sites📅 Started Jul 2024View details ↗
A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of JWK008 in Patients With Mucopolysaccharidosis Type I
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)
👨⚕️ Leigh R Hochberg, MD, Ph.D., Massachusetts General Hospital📍 1 site📅 Started Jul 2024View details ↗
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
👨⚕️ Brian Kushner, MD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started Jul 2024View details ↗
Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease
Single Stage Versus Multiple Staged Repair of Nasal & Alveolar Deformities in Patients With Cleft Lip and Palate
Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus
👨⚕️ Qiubai Li, Professor, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 2 sites📅 Started Jul 2024View details ↗
Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC
RecruitingNCT07291063 ↗
Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
RecruitingNCT07266675 ↗
Post-Acute Phase of Cardiogenic Shock
[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin
RecruitingNCT06430528 ↗
A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
RecruitingNCT06844877 ↗
Italian NCL Registry: a Registry for NCL as an Integration Tool for Future Therapeutic Strategies
👨⚕️ Filippo M Santorelli, Dr., IRCCS Fondazione Stella Maris📍 1 site📅 Started Jul 2024View details ↗
VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation
Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma
👨⚕️ Breffni Hannon, MB BCh BAO, MMedSci, MCFP, Princess Margaret Cancer Centre📍 1 site📅 Started Jul 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →